AbbVie (ABBV) capital expenditure was $1.2B in FY2025 (+25% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$1.2B
+25%
2024
$974M
+25%
2023
$777M
+12%
2022
$695M
-12%
2021
$787M
-1%
2020
$798M
+45%
2019
$552M
-13%
2018
$638M
+21%
2017
$529M
+10%
2016
$479M
-10%
2015
$532M
-13%
2014
$612M
+25%
2013
$491M
+47%
2012
$333M
-6%
2011
$356M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q2 2026
$322M
Q1 2026
$265M
Q4 2025
$329M
Q3 2025
$381M
Q2 2025
$269M
Q1 2025
$235M
Q4 2024
$291M
Q3 2024
$249M
Q2 2024
$241M
Q1 2024
$193M
Q4 2023
$205M
Q3 2023
$219M
Source: ABBV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.